Skip to main content

Table 1 Comparison between study groups regarding basic demographic characteristics, indication for myomectomy and myoma size, location, preoperative hemoglobin and hematocrit

From: Blood loss from transverse versus longitudinal uterine incision in abdominal myomectomy: a randomized controlled trial

 

Transverse uterine incision group (n = 25]

Longitudinal uterine incision group (n = 24]

p

Age (Yrs) Mean ± SD (95% CI)

28.84 ± 3.77 (27.2–30.3)

29.04 ± 4.68 (27.0–31.0)

0.86a

BMI (Kg/m2) Mean ± SD (95% CI)

24.36 ± 2.85 (23.1–25.5)

23.73 ± 2.45 (22.7–24.7)

0.41a

Parity

3 (1–4)

3 (2–5)

0.29b

Indication for myomectomy

 AUB

16 (64%)

15 (62.5%)

0.76c

 Pressure symptoms

5 (20%)

5 (20.8%)

 

 Infertility

1 (4%)

0 (0%)

 

 RPL

3 (12%)

4 (16.6%)

 

Mean myoma size (mm) Mean ± SD (95% CI)

81.72 ± 14.03 (75.9–87.5)

82.29 ± 9.85 (78.1–86.4)

0.87d

Myoma localization

  

0.70c

 Type 3

3 (12%)

2 (8.33%)

 

 Type 4

4 (16%)

4 (16.66%)

 

 Type 5

8 (32%)

4 (16.66%)

 

 Type 6

7 (28%)

10 (41.66%)

 

 Type 7

0

0

 

 Type 8

0

0

 

Hybrid myomas (Type 2–5)

3 (12%)

4 (16.66%)

 

Preoperative hemoglobin concentration (gm/dL) Mean ± SD (95% CI)

12.34 ± 0.97 (11.9–12.7)

12.63 ± 1.22 (12.1–13.1)

0.35d

Preoperative hematocrit (%) Mean ± SD (95% CI)

37.35 ± 3.01 (36.1–38.5)

38.25 ± 3.80 (36.6–39.8)

0.36d

  1. AUB, abnormal uterine bleeding; RPL, recurrent pregnancy loss
  2. aAnalysis using unpaired t-test
  3. bAnalysis using Mann–Whitney U-test
  4. cAnalysis using chi squared test
  5. dAnalysis using unpaired t-test with Welch’s correction
  6. eAccording to the Leiomyoma FIGO sub-classification system [18]